Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer
Journal of Clinical Oncology - United States
doi 10.1200/jco.2011.38.3224
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2012
Authors
Publisher
American Society of Clinical Oncology (ASCO)